{
  "title": "Cancer systems immunology reveals myeloid-T cell interactions and B cell activation mediate response to checkpoint inhibition in metastatic breast cancer.",
  "pmid": "40661534",
  "doi": null,
  "affiliations": [
    "University of Southern California, Department of Medicine, Division of Oncology, Keck School of Medicine, Los Angeles, CA.",
    "Department of Quantitative and Computational Biology, University of Southern California, Los Angeles, CA, USA.",
    "Department of Quantitative and Computational Biology, University of Southern California, Los Angeles, CA, USA.",
    "Department of Quantitative and Computational Biology, University of Southern California, Los Angeles, CA, USA.",
    "University of Southern California, Department of Surgery, Keck School of Medicine, Los Angeles, CA.",
    "University of Southern California, Department of Medicine, Division of Oncology, Keck School of Medicine, Los Angeles, CA.",
    "University of Southern California, Department of Medicine, Division of Oncology, Keck School of Medicine, Los Angeles, CA.",
    "University of Southern California, Department of Medicine, Division of Oncology, Keck School of Medicine, Los Angeles, CA.",
    "Johns Hopkins University, Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD.",
    "University of Southern California, Department of Medicine, Division of Oncology, Keck School of Medicine, Los Angeles, CA.",
    "Weill Cornell Medical Center, Cornell University, New York, NY.",
    "University College Cork, Cork, Ireland.",
    "Johns Hopkins University, Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD.",
    "University of Southern California, Department of Surgery, Keck School of Medicine, Los Angeles, CA.",
    "Department of Quantitative and Computational Biology, University of Southern California, Los Angeles, CA, USA.",
    "University of Southern California, Department of Medicine, Division of Oncology, Keck School of Medicine, Los Angeles, CA."
  ]
}